Fig. 1A case of stereotactic body radiation therapy (SBRT) for early stage lung cancer (T1N0M0). SBRT is conducted on the left lung cancer by focusing radiation from six directions. Axial view, 3D image of radiation dose distribution.
Reference |
Total dose (Gy) |
Daily dose (Gy) |
Reference point |
Local control n (%) |
Median follow-up (mo) |
Uematsu et al. (2001) [5] |
50-60 |
10 |
80% Margin |
47/50 (94) |
36 |
Arimoto et al. (1998) [8] |
60 |
7.5 |
Isocenter |
22/24 (92) |
24 |
Timmerman et al. (2010) [9] |
54 |
18 |
80% Margin |
54/55 (98) |
34 |
Onimaru et al. (2003) [7] |
48-60 |
6-7.5 |
Isocenter |
20/25 (80) |
17 |
Wulf et al. (2004) [10] |
45-56.2 |
15-15.4 |
80% Margin |
19/20 (95) |
10 |
Nagata et al. (2005) [6] |
48 |
12 |
Isocenter |
44/45 (97) |
30 |
Xia et al. (2006) [11] |
70 (50) |
7 (5) |
Isocenter |
41/43 (95) |
27 |
Baumann et al. (2009) [12] |
45 |
15 |
67% Margin |
53/57 (92) |
35 |
Table 1Results of various clinical trials of stereotactic body radiation therapy for lung cancer